Cindy E Neunert1, Robert W Gibson2, Peter A Lane3, Pragya Verma-Bhatnagar4, Vaughn Barry3, Mei Zhou5, Angela Snyder6. 1. Department of Pediatrics, Columbia University Medical Center and Morgan Stanley Children's Hospital, New York, New York. 2. Department of Emergency Medicine, Georgia Regents University, Augusta, Georgia. 3. Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, Georgia; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia. 4. Department of Pediatrics and Preventive Medicine, Quality of Life Health Services, Inc., Gadsden, Alabama. 5. Georgia Health Policy Center, Andrew Young School of Policy Studies, Georgia State University, Atlanta, Georgia. 6. Georgia Health Policy Center, Andrew Young School of Policy Studies, Georgia State University, Atlanta, Georgia; Department of Public Management and Policy, Andrew Young School of Policy Studies, Georgia State University, Atlanta, Georgia. Electronic address: angiesnyder@gsu.edu.
Abstract
INTRODUCTION: Advances in primary prophylaxis have resulted in improved outcomes for patients with sickle cell anemia (SCA; i.e., hemoglobin SS- and Sβ(0)-thalassemia). Standard prophylactic measures include a first pneumococcal polysaccharide vaccine (PPV) and transcranial Doppler ultrasound (TCD) at age 2 years. Though efficacious, evidence suggests that delivery of these interventions is suboptimal. This study reports adherence to these measures and examines concordance across various data sources, using Registry and Surveillance for Hemoglobinopathies project data. METHODS: Retrospective database and SCA center chart review identified children with SCA aged 24-36 months between January 1, 2004, and December 31, 2008. PPV and TCD administration were determined through Medicaid and Children's Health Insurance Program administrative claims data, medical record review, and Georgia Registry of Immunization Transaction and Services. Analysis was conducted in 2015. RESULTS: A total of 125 children met inclusion criteria. Forty-five (36.0%) children had documentation of both interventions, whereas 19 (15.2%) had no documentation of either intervention. Sixty-one (48.8%) children obtained only one intervention. Of these, more were likely to have had PPV than TCD (77.0% vs 23.0%, respectively, p<0.001). Agreement between claims data and medical record review was moderate for PPV (κ=0.55) and substantial for TCD (κ=0.74). CONCLUSIONS: No single, reliable data source for tracking standard of care for children with SCA statewide was found. According to study data, prophylaxis measures were not universally implemented during the surveillance period. Further research is needed to adequately track changes over time, determine risk groups, and develop methods of evaluating important metrics.
INTRODUCTION: Advances in primary prophylaxis have resulted in improved outcomes for patients with sickle cell anemia (SCA; i.e., hemoglobin SS- and Sβ(0)-thalassemia). Standard prophylactic measures include a first pneumococcalpolysaccharide vaccine (PPV) and transcranial Doppler ultrasound (TCD) at age 2 years. Though efficacious, evidence suggests that delivery of these interventions is suboptimal. This study reports adherence to these measures and examines concordance across various data sources, using Registry and Surveillance for Hemoglobinopathies project data. METHODS: Retrospective database and SCA center chart review identified children with SCA aged 24-36 months between January 1, 2004, and December 31, 2008. PPV and TCD administration were determined through Medicaid and Children's Health Insurance Program administrative claims data, medical record review, and Georgia Registry of Immunization Transaction and Services. Analysis was conducted in 2015. RESULTS: A total of 125 children met inclusion criteria. Forty-five (36.0%) children had documentation of both interventions, whereas 19 (15.2%) had no documentation of either intervention. Sixty-one (48.8%) children obtained only one intervention. Of these, more were likely to have had PPV than TCD (77.0% vs 23.0%, respectively, p<0.001). Agreement between claims data and medical record review was moderate for PPV (κ=0.55) and substantial for TCD (κ=0.74). CONCLUSIONS: No single, reliable data source for tracking standard of care for children with SCA statewide was found. According to study data, prophylaxis measures were not universally implemented during the surveillance period. Further research is needed to adequately track changes over time, determine risk groups, and develop methods of evaluating important metrics.
Authors: Violanda Grigorescu; Mary J Kleyn; Steven J Korzeniewski; William I Young; Wanda Whitten-Shurney Journal: Am J Prev Med Date: 2010-04 Impact factor: 5.043
Authors: K Ohene-Frempong; S J Weiner; L A Sleeper; S T Miller; S Embury; J W Moohr; D L Wethers; C H Pegelow; F M Gill Journal: Blood Date: 1998-01-01 Impact factor: 22.113
Authors: Natasha B Halasa; Sadhna M Shankar; Thomas R Talbot; Patrick G Arbogast; Ed F Mitchel; Winfred C Wang; William Schaffner; Allen S Craig; Marie R Griffin Journal: Clin Infect Dis Date: 2007-04-18 Impact factor: 9.079
Authors: Jean L Raphael; Priya B Shetty; Hao Liu; Donald H Mahoney; Brigitta U Mueller Journal: Pediatr Blood Cancer Date: 2008-11 Impact factor: 3.167
Authors: Barbara P Yawn; George R Buchanan; Araba N Afenyi-Annan; Samir K Ballas; Kathryn L Hassell; Andra H James; Lanetta Jordan; Sophie M Lanzkron; Richard Lottenberg; William J Savage; Paula J Tanabe; Russell E Ware; M Hassan Murad; Jonathan C Goldsmith; Eduardo Ortiz; Robinson Fulwood; Ann Horton; Joylene John-Sowah Journal: JAMA Date: 2014-09-10 Impact factor: 56.272
Authors: Emily Riehm Meier; Isaac A Janson; Kisha Hampton; Ellen Bloom; Natalie Duncan; Chris Roberson; Angeli Rampersad Journal: J Community Health Date: 2020-02
Authors: Christopher McKinney; Amy Caruso-Brown; Kathleen Montgomery; Anne Gillespie; Rebecca Coughlin; Dawn Law; Anna Brouwer; Lauren Tytler; Joanne Hilden; Rachelle Nuss Journal: Pediatr Qual Saf Date: 2020-01-10
Authors: Julie Kanter; Robert Gibson; Raymona H Lawrence; Matthew P Smeltzer; Norma L Pugh; Jeffrey Glassberg; Rita V Masese; Allison A King; Cecelia Calhoun; Jane S Hankins; Marsha Treadwell Journal: JAMA Netw Open Date: 2020-05-01